Open | 7.09 |
Previous Close | 7.08 |
Volume | 121.8 Thou. |
Average Volume | 276.4 Thou. |
Day's Range | 7.02 โ 7.14 |
52 Week Range | 5.7-13.33 |
Market Cap | 189 Mil. |
Moving Average (50) | 6.6404 |
Moving Average (200) | 8.66628 |
Earnings per Share (EPS) | -1.15 |
Price/Earnings (PE) | -6.11 |
Shares Outstanding | 26.89 Mil. |
Earnings Date | Aug 04, 2025 |
Beta | 1.654 |
Last Dividend | 0 |
INGN Latest News
|
|
|
|
|
Inogen, Inc., a medical technology company, develops, manufactures, and markets portable oxygen concentrators to patients, physicians and other clinicians, and third-party payors in the United States and internationally. Its oxygen concentrators are used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. The company offers Inogen One, a portable device that concentrate the air around the patient to provide a single source of supplemental oxygen; Inogen At Home stationary oxygen concentrators; Inogen Tidal Assist Ventilators, as well as related accessories. The company also rents its products directly to patients. Inogen, Inc. was incorporated in 2001 and is headquartered in Goleta, California.
About Inogen | |
Industry | Medical - Devices |
Sector | Healthcare |
Number of Employees | 766 |
Website & Executive | |
Website | https://www.inogen.com |
CEO (Chief Executive Officer) | Kevin R. M. Smith |
IPO date | 2014-02-14 |
Contact | |
Country | US |
Address | 301 Coromar Drive |
City | Goleta |
State | CA |
Phone | 805 562 0500 |
Zip Code | 93117 |
Other Identifiers | |
CIK | 0001294133 |
ISIN | US45780L1044 |
CUSIP | 45780L104 |